CLINICAL_TRIALS trial_result · 2021-04-19

Clinical Trial Update: A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia [Phase 2]

Phase 2 trial update for LY3202626 in mild Alzheimer's disease dementia was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Alzheimer's Disease | Phase 2 | Status: TERMINATED | Results posted: 2021-04-19